Shopping Cart
Remove All
Your shopping cart is currently empty
Upadacitinib is a potent and selective JAK inhibitor. Upadacitinib is approximately 74 fold selective for Jak1 over Jak2 in cellular assays dependent on specific, relevant cytokines. Upadacitinib demonstrates efficacy in rat arthritis models.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,970 | 1-2 weeks | 1-2 weeks | |
| 50 mg | $2,580 | 1-2 weeks | 1-2 weeks | |
| 100 mg | $3,400 | 1-2 weeks | 1-2 weeks |
| Description | Upadacitinib is a potent and selective JAK inhibitor. Upadacitinib is approximately 74 fold selective for Jak1 over Jak2 in cellular assays dependent on specific, relevant cytokines. Upadacitinib demonstrates efficacy in rat arthritis models. |
| Targets&IC50 | JAK1:0.043 μM, JAK2:0.2 μM, Tyk2:4.7 μM, JAK3:2.3 μM |
| Synonyms | ABT-494, ABT494, ABT 494 |
| Molecular Weight | 602.521 |
| Formula | C21H33F3N6O11 |
| Cas No. | 1607431-21-9 |
| Smiles | O.O.O.O.O[C@H]([C@@H](O)C(O)=O)C(O)=O.CC[C@@H]1CN(C[C@@H]1c1cnc2cnc3[nH]ccc3n12)C(=O)NCC(F)(F)F |
| Relative Density. | 1.31g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.